Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of […]
Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical genomics community PLEASANTON, Calif. — n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al’Khafaji […]
US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360 SCHLIEREN, Switzerland & MUNICH — PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before the U.S. Patent Trial and Appeal Board (PTAB). The PTAB has revoked the central claims of U.S. Patent […]
COLUMBIA, Md. — Shimadzu Scientific Instruments Inc., a Shimadzu Group company, has officially opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications and lab automation solutions tailored to the needs of pharmaceutical […]
SAN JOSE, Calif. & RENO, Nev. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide. The companies are collaborating to develop verified automation methods and workflows for Takara Bio […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today the appointment of Camila Japur as Chief Financial Officer, who will join the company on June 1, 2026. Camila currently serves as Group CFO of u-blox, where she has successfully led transformation initiatives, driving cost efficiency, strengthening financial processes, and enhancing capital market […]
The AutoNorm™ adaptive amplification technology transforming library preparation at leading genomics cores is now available in a 16-well format, purpose-built for labs running smaller sequencing batches and who refuse to compromise on data quality. PLEASANTON, Calif. — In 2024, n6 introduced icon96™, redefining expectations for PCR amplification in NGS library preparation. By monitoring each well in real […]
Shelton, CT – PerkinElmer, a global leader in analytical solutions and specialized services for the life sciences, applied, and food markets, today announced that Michael Stubblefield has been appointed as the company’s new Chief Executive Officer, succeeding Dirk Bontridder. Michael joins PerkinElmer at an important moment in the company’s evolution as a standalone business following […]
IDT has launched its first in vitro diagnostic NGS assays—Archer FUSION Plex™‑HT Dx and VARIANT Plex™‑HT Dx—marking its entry into the clinical diagnostics market with standardized, IVD‑grade solutions for oncology workflows. Milestone marks first of multiple planned diagnostic product launches on NGS roadmap Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro diagnostic […]
Royston Instruments Announces Acquisition of Controlling Stake in Biosan, Strengthening Global Life-Science and Laboratory Instrumentation Capabilities Royston, United Kingdom, 19th March 2026, Royston Instruments Ltd, a diversified technology group focused on advancing scientific instrumentation and data acquisition solutions, today announced that it has acquired a controlling stake in Biosan SIA, the Riga-based developer and manufacturer […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
